SCHEMBL12419013

SCHEMBL12419013

CCCCCCCCCCCCCC(O)CC(=O)CO

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.66
FFAR1 O14842 2/20 0.53
FFAR4 Q5NUL3 1/20 0.53
TRPV1 Q8NER1 1/20 0.50
PSMD14 O00487 2/20 0.47
PLA2G1B P04054 2/20 0.47
MMP2 P08253 2/20 0.47
ATG4B Q9Y4P1 2/20 0.47
HSP90AA1 P07900 1/20 0.47
RAD52 P43351 1/20 0.47
NFKB1 P19838 1/20 0.47
CYP2D6 P10635 2/20 0.46
SPHK1 Q9NYA1 1/20 0.46
GMNN O75496 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
THPO P40225 1/20 0.46
MTOR P42345 1/20 0.46
BLM P54132 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12396669 1.00 GPR84 (0.66) GPR84FFAR1FFAR4TRPV1PSMD14
SCHEMBL8817418 0.88 GPR84 (0.66) GPR84FFAR1FFAR4TRPV1NFKB1
SCHEMBL9449753 0.88 GPR84 (0.66) GPR84FFAR1FFAR4TRPV1NFKB1
SCHEMBL14640803 0.86 GPR84 (0.68) GPR84FFAR1FFAR4TRPV1PSMD14
SCHEMBL17002061 0.86 GPR84 (0.68) GPR84FFAR1FFAR4TRPV1PSMD14
SCHEMBL29074530 0.84 FFAR1 (0.69) GPR84FFAR1FFAR4NFKB1MAPT
SCHEMBL8024625 0.84 FFAR1 (0.69) GPR84FFAR1FFAR4NFKB1MAPT
SCHEMBL7058832 0.83 GPR84 (0.64) GPR84FFAR1FFAR4TRPV1NFKB1
SCHEMBL23728247 0.82 GPR84 (0.63) GPR84FFAR1FFAR4TRPV1PSMD14
SCHEMBL23728329 0.82 GPR84 (0.63) GPR84FFAR1FFAR4TRPV1PSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8734823-B2 Device including altered microorganisms, and methods and systems of use THE INVENTION SCIENCE FUND I, LLC (US) 2014-05-27 US disclosed
US-8682619-B2 Device including altered microorganisms, and methods and systems of use THE INVENTION SCIENCE FUND I, LLC (US) 2014-03-25 US disclosed
US-20110172826-A1 Device including altered microorganisms, and methods and systems of use SEARETE LLC 2011-07-14 US disclosed
US-20110027181-A1 Device including altered microorganisms, and methods and systems of use SEARETE LLC 2011-02-03 US disclosed
US-20110028945-A1 Device including altered microorganisms, and methods and systems of use SEARETE LLC, 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110027181-A1 Device including altered microorganisms, and methods and systems of use DNASE1, MTREX, POLI GPR84 816/4885FFAR1 2148/4885FFAR4 2773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.